BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 27
• 30
• 31

• FDA

  Genzyme Corporation’s Lemtrada™ Approved In Australia For Treatment Of Multiple Sclerosis

  December 19, 2013

   · 

  7 min read
• BioMidwest

  Aastrom Biosciences, Inc. Granted Composition-Of-Matter Patent For Ixmyelocel-T In Australia

  December 19, 2013

   · 

  1 min read
• Drug Development

  NovaBay Pharmaceuticals, Inc. Announces Plan To Reinitiate Clinical Evaluation Of Auriclosene For Impetigo In 2014

  December 19, 2013

   · 

  1 min read
• Biotech Bay

  Oculus Innovative Sciences, Inc. Pays Off Debt To Strengthen Balance Sheet; Obtains $4.5 Million In Stockholders’ Equity On A Pro Forma Basis As Of September 30, 2013, Sufficient To Regain Compliance With NASDAQ Listing Rules

  December 19, 2013

   · 

  1 min read
• Royal DSM Announces Final Terms Of EU300 Million Bond

  December 19, 2013

   · 

  1 min read
• Drug Development

  Galectin Therapeutics Release: Published Preclinical Study Demonstrates Therapeutic Effect Of Galectin Inhibitors In Fatty Liver Disease With Fibrosis

  December 19, 2013

   · 

  1 min read
• 2013 Marks Incisive Year For Clinical CRO, ICRC-Weyer

  December 19, 2013

   · 

  3 min read
• Business

  MorphoSys AG Strengthens Clinical Development Organization With Three Management Appointments

  December 19, 2013

   · 

  1 min read
• Drug Development

  Athersys, Inc. Confirms Completion Of Patient Enrollment Of Pfizer Inc.'s Phase II Study Of Multistem® Cell Therapy For Ulcerative Colitis

  December 19, 2013

   · 

  1 min read
• Genetown

  Verastem, Inc. Announces Addition To The NASDAQ Biotechnology Index

  December 19, 2013

   · 

  1 min read